Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delgocitinib cream versus vehicle for palmoplantar pustulosis
2024-518856-21-00Phase 2Authorised
- Sponsor
- LEO Pharma
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, randomised, double-blind trial in Palmoplantar Pustular Psoriasis (PPPP) comparing Delgocitinib cream with Cream vehicle (2 arms). Primary endpoint: PPPASI-75 at Week 16. Planned start Aug 2025; status: authorised.
02
Drugs
delgocitinib
03
Conditions
Palmoplantar Pustular Psoriasis (PPPP)
Beyond the preview
Go deeper on 2024-518856-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518856-21-00.